Security key
15117F500
Cellectar Biosciences, Inc. - Common Stock (CLRB)
CUSIP: 15117F500
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,719,970
- Total 13F shares
- 17,679,705
- Share change
- +10,953,255
- Total reported value
- $36,895,000
- Price per share
- $2.08
- Number of holders
- 38
- Value change
- +$23,156,825
- Number of buys
- 26
- Number of sells
- 8
Report period
Q4 2020
Institutions
38
Top holders
10
CLRB full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117F500
Recent filing periods:
Top shareholders of CLRB - Cellectar Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Sio Capital Management, LLC |
13F
|
Company |
16%
|
1,364,457
|
$1,692,000 | — | 30 Sep 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
11%
|
920,000
|
$1,141,000 | — | 30 Sep 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
5.1%
|
441,327
|
$547,000 | — | 30 Sep 2020 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
2.3%
|
203,321
|
$252,000 | — | 30 Sep 2020 | |
| Worth Venture Partners, LLC |
13F
|
Company |
2%
|
175,350
|
$218,000 | — | 30 Sep 2020 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1%
|
87,500
|
$109,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.81%
|
70,837
|
$88,000 | — | 30 Sep 2020 | |
| Quilter Plc |
13F
|
Company |
0.67%
|
58,102
|
$72,000 | — | 30 Sep 2020 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.51%
|
44,839
|
$56,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.29%
|
25,085
|
$31,000 | — | 30 Sep 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.2%
|
17,485
|
$22,000 | — | 30 Sep 2020 | |
| Independence Advisors, LLC |
13F
|
Company |
0.11%
|
10,000
|
$12,000 | — | 30 Sep 2020 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.11%
|
10,000
|
$12,000 | — | 30 Sep 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.11%
|
9,404
|
$11,000 | — | 30 Sep 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.06%
|
5,619
|
$7,000 | — | 30 Sep 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
3,000
|
$4,000 | — | 30 Sep 2020 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
2,857
|
$4,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
2,219
|
$3,000 | — | 30 Sep 2020 | |
| Prospera Financial Services Inc |
13F
|
Company |
0.01%
|
1,000
|
$1,000 | — | 30 Sep 2020 |
Institutional Holders of Cellectar Biosciences, Inc. - Common Stock (CLRB) as of Q4 2020
As of 31 Dec 2020,
Cellectar Biosciences, Inc. - Common Stock (CLRB) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,679,705 shares.
The largest 10 holders included
Consonance Capital Management LP, Sio Capital Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, Maven Securities LTD, VANGUARD GROUP INC, 683 Capital Management, LLC, BOXER CAPITAL, LLC, Altium Capital Management LP, BlackRock Inc., and Tri Locum Partners LP.
This page lists
38
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
19
Q4 2020 holders
38
Holder diff
19
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.